Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
  2. 8-K Event Agreement ended · Executive or director change
  3. 8-K Event Agreement ended · Other events
  4. 10-K/A Report 10-K/A
  5. 10-K Report Annual Report
  6. 8-K Event Auditor change
  7. 8-K Event Material agreement · Executive or director change · Other events
  8. 8-K Event Material agreement · Unregistered share sale · Other events
  9. 8-K Event Executive or director change · Shareholder vote results
  10. DEF 14A Proxy Proxy Statement
  11. 8-K/A Event Executive or director change
  12. 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Executive or director change
  13. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  14. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
  15. 8-K/A Event Exhibits
  16. 8-K Event Material agreement · Agreement ended · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  17. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
  18. 8-K Event Bylaws or fiscal year change
  19. DEF 14A Proxy Proxy Statement
  20. 8-K Event Director nominations

Page 1 of 11 · 202 filings